According to research carried out on patients with liver cancer from China and southern Africa, a mutational hotspot at codon 249 of the p53 tumor suppressor gene has been identified (Hsu et al., 1993), and HBV and aflatoxin B1 (AFB1) are known synergistic risk factors. This evidence concerns the gene TP53 and liver cancer.